FOX BIZ NEWS: Johnson & Johnson posts strong third quarter earnings after pause in coronavirus vaccine study


Johnson & Johnson posts strong third quarter earnings after pause in coronavirus vaccine study



Johnson & Johnson reported a strong third quarter performance on Tuesday following an announcement that it is pausing its coronavirus vaccine research study.

Comments

Popular posts from this blog

Covid live: Record 50,000+ infections on Sunday

Impact of pandemic? Women jobseekers fell by 34% in 2021

SC slams trial courts for seeking needless custody